Waiting for the Other Shoe to Drop
The curse of the canine itch. If you’ve ever dealt with it, you know the agony of self-mutilation, non-stop chewing and scratching, lost sleep, and often great expense with minimal results.
That seemed to shift when Apoquel came out. Magically less itchy, often within hours of a pill!
The expense was significant, but who cares, when your dog stops scratching and the whole household can finally get some serious sleep?
The other shoe on Apoquel seems to drop at varying intervals after first starting the immune tweaking drug.
After the first dose for some of you, or later on, tumors growing in various places, or other immune related diseases cropping up.
And many experienced a steady decline in efficacy. In other words, it worked less and less well each time it was dosed.
More expense, less results for your itchy dog.
This article and its many comments suggest you should tread carefully if you’re considering using Apoquel by Zoetis.
The New Drug on the Block: Get Mabbed
Likely encouraged by the huge rush of profits for its shareholders, Zoetis, the vet pharma giant, brought out another immune tweaking drug, first called CADI (Canine Atopic Dermatitis Immunotherapeutic), but finally marketed as Cytopoint. [Read more…] about Cytopoint: High Tech Answer to Your Itchy Dog?